Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metformin+Sitagliptin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06124560
What this trial is testing

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 100 mg /1000 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Who this might be right for
BioequivalenceDiabetes Mellitus, Type 2
Galenicum Health 58
Large-scale testing (Phase 3)Study completedNCT00838903
What this trial is testing

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 1,049
Post-approval studies (Phase 4)Study completedNCT02512523
What this trial is testing

Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 39
Large-scale testing (Phase 3)Study completedNCT00676338
What this trial is testing

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 820
Not applicableStudy completedNCT07763912
What this trial is testing

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 50 mg/1000 mg in Healthy Subjects, Fed Study.

Who this might be right for
Bioequivalence
ADIUM 46
Large-scale testing (Phase 3)Study completedNCT01545388
What this trial is testing

Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 337
Large-scale testing (Phase 3)Ended earlyNCT01477853
What this trial is testing

The Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 166
Post-approval studies (Phase 4)Study completedNCT00993187
What this trial is testing

Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 292
Large-scale testing (Phase 3)Study completedNCT03061214
What this trial is testing

Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin in Subjects With Type 2 Diabetes (SUSTAIN - CHINA MRCT)

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 868
Large-scale testing (Phase 3)Study completedNCT01455870
What this trial is testing

Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Intarcia Therapeutics 535
Large-scale testing (Phase 3)Study completedNCT01702298
What this trial is testing

Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 42
Not applicableStudy completedNCT07172269
What this trial is testing

Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Iraqi Patients With Type 2 Diabetes

Who this might be right for
Diabete MellitusType 2 DiabetesObesity Type 2 Diabetes Mellitus+2 more
Mais Qais Hbeeb 58
Large-scale testing (Phase 3)Study completedNCT00637273
What this trial is testing

Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 514
Testing effectiveness (Phase 2)Study completedNCT01338870
What this trial is testing

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 301
Large-scale testing (Phase 3)Study completedNCT02567994
What this trial is testing

Tenelia Triple Combination Study

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 201
Large-scale testing (Phase 3)Study completedNCT00885352
What this trial is testing

Sitagliptin (MK-0431) vs. Placebo in Patients With Inadequate Glycemic Control on Metformin With Pioglitazone (MK-0431-128)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 313
Early research (Phase 1)Study completedNCT00929201
What this trial is testing

Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 61
Large-scale testing (Phase 3)Study completedNCT01296412
What this trial is testing

Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)

Who this might be right for
Diabetes Mellitus, Type 2
Merck Sharp & Dohme LLC 653
Large-scale testing (Phase 3)UnknownNCT00684528
What this trial is testing

A Double-Blind, Randomized, Active-Comparator (Metformin) Controlled, Clinical Trial to Study the Efficacy and Safety of the Strategy to Start Patients With Type 2 Diabetes Mellitus on Janumet™ Compared to Metformin

Who this might be right for
Diabetes Type 2
Meir Medical Center 1,000
Testing effectiveness (Phase 2)Study completedNCT00642278
What this trial is testing

An Efficacy, Safety, and Tolerability Study of Canagliflozin (JNJ-28431754) in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type IIDiabetes Mellitus, Non Insulin Dependent
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 451
Next Page